Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

SHE:002653 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,298	1,056	1,169	775.39	575.11	453.97
Short-Term Investments	-	-	-	-	-	410
Trading Asset Securities	-	150.13	160.06	-	-	370.32
Cash & Short-Term Investments	1,298	1,206	1,329	775.39	575.11	1,234
Cash Growth	-13.99%	-9.23%	71.37%	34.82%	-53.41%	0.91%
Accounts Receivable	1,117	1,077	883.9	803.79	569.97	487.61
Other Receivables	36.85	40.35	46.79	47.14	78.5	68.54
Receivables	1,154	1,117	930.69	850.93	648.47	556.16
Inventory	317.2	271.61	281.29	346	259.95	223.9
Prepaid Expenses	-	22.55	-	-	-	-
Other Current Assets	90.68	112.53	100.02	81.32	64.9	81.38
Total Current Assets	2,860	2,730	2,641	2,054	1,548	2,096
Property, Plant & Equipment	882.56	917.09	996.04	1,074	1,137	1,126
Long-Term Investments	135.83	146.99	232.46	422.17	381.19	398.83
Other Intangible Assets	1,240	1,277	751.23	708.33	682.47	599.98
Long-Term Deferred Tax Assets	172.54	177.23	148.24	126.08	83.57	80.6
Long-Term Deferred Charges	1,157	1,107	1,427	1,233	822.42	587.16
Other Long-Term Assets	477.25	443.95	457.37	430.15	350.51	108.15
Total Assets	6,925	6,798	6,653	6,048	5,005	4,997
Accounts Payable	174.53	195.89	208.99	242.44	301.4	419.95
Accrued Expenses	74.17	190.48	200.09	136.68	120.63	93.13
Short-Term Debt	82.45	242.57	99.98	484.69	452.18	740
Current Portion of Long-Term Debt	921.72	728.41	833.59	295.4	325.78	-
Current Portion of Leases	-	10.27	7.41	6.64	8	-
Current Income Taxes Payable	38.97	5.49	16.08	16.1	1.71	47.73
Current Unearned Revenue	22.24	20.87	14.61	26.96	28.44	26.02
Other Current Liabilities	185.83	174.23	123.23	279.64	279.98	389.4
Total Current Liabilities	1,500	1,568	1,504	1,489	1,518	1,716
Long-Term Debt	1,200	925	854.68	1,320	452.41	334.9
Long-Term Leases	5.4	4.14	10.85	4.52	10.91	-
Long-Term Unearned Revenue	98.26	95.06	108.47	98.52	102.54	87.14
Long-Term Deferred Tax Liabilities	7.53	3.77	4.01	2.53	1.11	1.33
Other Long-Term Liabilities	-	-	0.38	-	-	2.23
Total Liabilities	2,811	2,596	2,482	2,914	2,085	2,142
Common Stock	1,120	1,120	1,114	1,076	1,077	1,074
Additional Paid-In Capital	968.76	953.57	853.38	100.82	97.62	78.57
Retained Earnings	2,067	2,180	2,210	1,807	1,733	1,787
Treasury Stock	-80.94	-80.94	-9.15	-24.44	-38.31	-24.76
Comprehensive Income & Other	41.61	40.55	11.86	76.41	-26.82	-13.3
Total Common Equity	4,116	4,213	4,180	3,036	2,842	2,902
Minority Interest	-2.04	-11.09	-9.36	97.68	78.27	-47.65
Shareholders' Equity	4,114	4,202	4,171	3,133	2,920	2,855
Total Liabilities & Equity	6,925	6,798	6,653	6,048	5,005	4,997
Total Debt	2,209	1,910	1,807	2,111	1,249	1,075
Net Cash (Debt)	-911.18	-704.22	-477.74	-1,336	-674.16	159.39
Net Cash Growth	-	-	-	-	-	11.29%
Net Cash Per Share	-0.80	-0.62	-0.44	-1.25	-0.63	0.15
Filing Date Shares Outstanding	1,165	1,159	1,048	1,036	1,091	1,137
Total Common Shares Outstanding	1,165	1,159	1,048	1,036	1,091	1,137
Working Capital	1,360	1,162	1,137	565.09	30.32	379.5
Book Value Per Share	3.53	3.63	3.99	2.93	2.61	2.55
Tangible Book Value	2,876	2,937	3,429	2,327	2,159	2,302
Tangible Book Value Per Share	2.47	2.53	3.27	2.25	1.98	2.03
Buildings	-	931.33	965.52	922.14	931.62	684.59
Machinery	-	789.01	748.62	709.94	677.15	602.24
Construction In Progress	-	6.73	5.87	97.9	88.54	335.2

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.